http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24962707

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 175
issn 1433-7398
1861-387X
issueIdentifier 3
pageRange 169-175
publicationName Brain Tumor Pathology
startingPage 169
bibliographicCitation Takano S, Kato Y, Yamamoto T, Liu X, Ishikawa E, Kaneko MK, Ogasawara S, Matsuda M, Noguchi M, Matsumura A. Diagnostic advantage of double immunohistochemistry using two mutation-specific anti-IDH antibodies (HMab-1 and MsMab-1) in gliomas. Brain Tumor Pathol. 2015 Jul;32(3):169–75. doi: 10.1007/s10014-015-0214-8. PMID: 25652153.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e8cc39f883db40db067f481be6956e7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1521773a45a915bff51876d78fdca4eb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4c7bf05e19bcb516acff9c875f685aa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc7f579f7628d4c352929f9efef60e9a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e99db66af874eac200f6abfbbbd6e66
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9478a6e8d1fca88a91a685ea7205a40c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c31b547d3de3248228d037329d76acc5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5385-8201
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6fba0c63d6633e3d27941cd8782c8b1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78bb2eb2cbc9a455db17e4ea4d651312
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a3303acf8230361a84a0f311e830881
date 2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/25652153
https://doi.org/10.1007/s10014-015-0214-8
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20741
https://portal.issn.org/resource/ISSN/1861-387X
https://portal.issn.org/resource/ISSN/1433-7398
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title Diagnostic advantage of double immunohistochemistry using two mutation-specific anti-IDH antibodies (HMab-1 and MsMab-1) in gliomas
discusses http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0533281
http://id.nlm.nih.gov/mesh/M0022149
http://id.nlm.nih.gov/mesh/M0539173
http://id.nlm.nih.gov/mesh/M0011751
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93456
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_281c3deab424c97785a96e0444a0943e
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c09812e6766ef2f1e11efd56052399b5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7e4d19766b8958e96da36c9f9cf8a76
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7839

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3418
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3417

Total number of triples: 43.